BDWM
EW icon

Brewin Dolphin Wealth Management’s Edwards Lifesciences EW Stock Holding History

Brewin Dolphin Wealth Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$13K Buy
+132
New +$13.7K ﹤0.01% 274
2022
Q1 		– Sell
-300
Closed -$39K – 377
2021
Q4 		$39K Buy
+300
New +$35K ﹤0.01% 213

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Brewin Dolphin Wealth Management's EW Position: Q2 2022 in Review

Brewin Dolphin Wealth Management opened a new position in Edwards Lifesciences (EW) in Q2 2022: 132 shares worth $13K. The stake represents ﹤0.01% of the portfolio and ranks #274 among its holdings. This is a return to the name: Brewin Dolphin Wealth Management previously reported a position in EW as recently as Q4 2021.

Brewin Dolphin Wealth Management first reported a position in EW in Q4 2021 and has held it in 2 quarters since. The position peaked at $39K in Q4 2021. 1,272 funds tracked by Wall St. Rank hold EW as of Q2 2022.

  • Brewin Dolphin Wealth Management held 132 shares of Edwards Lifesciences worth $13K as of Q2 2022.
  • Edwards Lifesciences was a new Brewin Dolphin Wealth Management position in Q2 2022.
  • Edwards Lifesciences made up ﹤0.01% of Brewin Dolphin Wealth Management's portfolio in Q2 2022, its #274 holding.
  • Brewin Dolphin Wealth Management first reported a position in Edwards Lifesciences in Q4 2021 and has held it in 2 quarters since.
  • Brewin Dolphin Wealth Management's Edwards Lifesciences position peaked at $39K in Q4 2021.
  • 1,272 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2022.

Based on Brewin Dolphin Wealth Management's 13F filing for Q2 2022, filed 14 Nov 2022.